Literature DB >> 17366289

General practitioners' needs for ongoing support for the interpretation of spirometry tests.

Patrick J P Poels1, Tjard R J Schermer, Reiner P Akkermans, Annelies Jacobs, Margreet van den Bogart-Jansen, Ben J A M Bottema, Chris Van Weel.   

Abstract

BACKGROUND: Although one out of three general practitioners (GPs) carries out spirometry, the diagnostic interpretation of spirometric test results appears to be a common barrier for GPs towards its routine application.
METHODS: Multivariate cross-sectional analysis of a questionnaire survey among 137 GPs who participated in a spirometry evaluation programme in the Netherlands. We identified characteristics of GPs and their practice settings associated with GPs' need for ongoing support for spirometry interpretation.
RESULTS: Response rate on the survey questionnaire was 98%. The need for ongoing support among the participating GPs was 69%. GPs' recent spirometry training showed a statistically significant association with the need for ongoing support for the interpretation of spirometry (odds ratio 0.43, 95% CI 0.20-0.92).
CONCLUSION: There is a need for ongoing support for spirometry interpretation among GPs. Recent spirometry training partially diminished this need.

Mesh:

Year:  2007        PMID: 17366289     DOI: 10.1080/13814780601084193

Source DB:  PubMed          Journal:  Eur J Gen Pract        ISSN: 1381-4788            Impact factor:   1.904


  2 in total

1.  A telehealth integrated asthma-COPD service for primary care: a proposal for a pilot feasibility study in Crete, Greece.

Authors:  Ioanna G Tsiligianni; Thys van der Molen; Nikolaos E Tzanakis; Nikolaos M Siafakas; Ellen van Heijst; Christos Lionis
Journal:  BMC Res Notes       Date:  2010-07-15

2.  Evaluation of current knowledge, awareness and practice of spirometry among hospital -based Nigerian doctors.

Authors:  Olufemi O Desalu; Olusegun A Busari; Cajetan C Onyedum; Fatai K Salawu; Olusegun A Obateru; Kelechukwu C Nwogu; Alakija K Salami
Journal:  BMC Pulm Med       Date:  2009-12-14       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.